Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy
article
OA: green
CC0
⤵ 10 in-corpus citations
Abstract
OBJECTIVE: To develop a risk-factor score that may provide additional guidance to women and their physicians regarding elective bilateral salpingo-oophorectomy at the time of hysterectomy. METHODS: From a case-control study conducted from 1992 to 2008 in women residing in eastern Massachusetts or New Hampshire, we selected 1,098 women with invasive ovarian cancer (case group) and 1,363 for the control group who were older than 40 years and had neither hysterectomy nor a personal or family history of breast or ovarian cancer. Using logistic regression, we identified key risk factors and built a risk score. The score was separately assessed in 126 women in the case group and 156 in the control group with excluded prior hysterectomy to determine whether women who developed ovarian cancer could have been distinguished. RESULTS: Summing eight conditions found to be associated with ovarian cancer (Jewish ethnicity, less than 1 year of oral contraceptive use, nulliparity, no breastfeeding, no tubal ligation, painful periods or endometriosis, polycystic ovary syndrome or obesity, talc use), we created a five-level score. Assigning average risk to those with a score of 2, the odds ratios varied from 0.56 (95% confidence interval [CI] 0.42-0.74) for a score of 0-1 to 3.30 (95% CI 2.50-4.35) for a score of 5 or greater (P trend <.001). The risk score was higher for women who developed ovarian cancer after hysterectomy than those who did not (P=.01). Lifetime risks for ovarian cancer for a woman at age 40 years are changed from 1.2% with a 0-1 score to 6.6% with a score of 5 or higher. CONCLUSION: We developed a risk-assessment tool that can quantify women's risk for ovarian cancer and should be validated in other data sets.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (35)
- Endometriosis and ovarian cancer: A review via openalex
- Endometriosis and ovarian cancer: A review via openalex
- Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study via openalex
- The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas via openalex
- W1991757464 via openalex
- W2000175691 via openalex
- W2013646480 via openalex
- W2022153701 via openalex
- W2023356051 via openalex
- W2027006764 via openalex
- W2027487470 via openalex
- W2036687174 via openalex
- W2041518096 via openalex
- W2056549981 via openalex
- W2056818059 via openalex
- W2057675594 via openalex
- W2071540706 via openalex
- W2071669935 via openalex
- W2078922978 via openalex
- W2090702820 via openalex
- W2097104948 via openalex
- W2118435847 via openalex
- W2120913902 via openalex
- W2142647903 via openalex
- W2172175527 via openalex
- W2398110124 via openalex
- W2401589429 via openalex
- W2735861455 via openalex
- W2918154310 via openalex
- W4255463338 via openalex
- W1442973484 via openalex
- W6628199790 via openalex
- W1976198926 via openalex
- W1976274871 via openalex
- W1978160584 via openalex
Cited by (10)
- A framework for assessing interactions for risk stratification models: the example of ovarian cancer 2023
- Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk 2021
- Peripheral Blood Leukocyte Telomere Length and Endometriosis 2020
- Clinical implication for endometriosis associated with ovarian cancer 2017
- Vaginal Salpingo-Oophorectomy 2017
- The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses 2016
- L’endométriose est-elle une lésion pré-cancéreuse ? Perspectives et implications cliniques 2016
- Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery 2015
- Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis 2014
- Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0
· commercial use OK